4-(Methylsulfonyl)phenylacetic Acid CAS 90536-66-6 Purity >99.5% (HPLC) Etoricoxib Intermediate Factory

Chemical Name: 4-(Methylsulfonyl)phenylacetic Acid  CAS: 90536-66-6 Purity: >99.5% (HPLC) Appearance: White to Off-White Solid Powder Intermediate of Etoricoxib (CAS: 202409-33-4) High Quality, Commercial Production Contact: Dr. Alvin Huang Mobile/Wechat/WhatsApp: +86-15026746401 E-Mail: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureLeading Manufacturer and Supplier, Intermediates of Etoricoxib Etoricoxib API CAS 202409-33-4 4-(Methylthio)Phenylacetic Acid CAS 16188-55-9 4-(Methylsulfonyl)Phenylacetic Acid CAS 90536-66-6  Please contact: alvin@ruifuchem.com
Item Specifications
Appearance White to Off-White Solid Powder
Purity / Analysis Method >99.5% (HPLC) 
Melting Point 136.0 to 140.0℃
Moisture (K.F) <0.50%
Single Largest Impurity <0.30%
Total Impurities <0.50%
Infrared Spectrum Conforms to Structure 
Test Standard Enterprise Standard
Usage Intermediate of Etoricoxib (CAS: 202409-33-4)

Description:

Specifications:

Package & Storage:

Chemical Name 4-(Methylsulfonyl)phenylacetic Acid
Synonyms 4-Methylsulphonylphenylacetic Acid; 4-(Methanesulfonyl)phenylacetic Acid; (4-Methanesulfonylphenyl)acetic Acid; 4-Methylsulfonyl Phenyl Acetic Acid; 2-(4-(Methylsulfonyl)phenyl)acetic Acid; [p-(Methylsulfonyl)phenyl]-Acetic Acid; 4-Mesylphenylacetic Acid
CAS Number 90536-66-6
CAT Number RF-PI1182
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C9H10O4S
Molecular Weight 214.24  
Melting Point 136.0 to 140.0℃
Density   1.35
Solubility Soluble in Methanol
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

4-(Methylsulfonyl)phenylacetic Acid (CAS: 90536-66-6) is an intermediate of Etoricoxib (CAS: 202409-33-4). Etoricoxib is a kind of highly selective cyclooxygenase-2 (COX-2) inhibitors developed by the Merck company. Etoricoxib is widely used in treatment of osteoarthritis (OA), rheumatoid arthritis, ankylosing spondylitis, chronic low back pain, acute gouty arthritis, primary dysmenorrhea and postoperative pain, and other diseases. Etoricoxib, a selective COX-2 inhibitor, has anti-inflammatory, analgesic and antipyretic effects, suitable for the treatment of symptoms and signs of acute and chronic osteoarthritis, as well as acute gouty arthritis. Etoricoxib is rapidly absorbed, with an oral bioavailability of 80 to 100%, and reaches maximum plasma concentrations in 1 to 2 hours after dosing. Food decreases the rate of absorption but has no effect on the extent of absorption. It exhibits a long elimination half-life of approximately 22 hours, demonstrating linear plasma pharmacokinetics with no accumulation during multiple dosing.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours